Prevalence of reporting clinician recommendation was lower for non-Hispanic Asian, Black, Hispanic versus White adults<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Sept. 12, 2023 (HealthDay News) — Only about one-quarter of adults who are overdue for colorectal cancer (CRC) screening receive a recommendation from their clinician, according to a research letter published online Sept. 12 in the Annals of Internal Medicine<\/em>.<\/p>\n Jordan Baeker Bispo, Ph.D., M.P.H., from the American Cancer Society in Kennesaw, Georgia, and colleagues estimated the prevalence of receiving a clinician recommendation for CRC screening among underscreened U.S. adults using pooled data from the 2019 and 2021 National Health Interview Survey. A total of 5,022 adults who were eligible and overdue for CRC screening and had undergone a wellness visit in the past year were included in the analysis.<\/p>\n The researchers found that overall, 26.8 percent of these adults reported receiving a clinician recommendation for CRC screening. The prevalence varied from less than 10 to 32 percent for adults without a usual source of care and for those with a family income exceeding 400 percent of the federal poverty level, respectively. The prevalence of reporting a clinician recommendation for CRC screening was lower for non-Hispanic Asian, non-Hispanic Black, and Hispanic adults than non-Hispanic Whites (adjusted prevalence ratios, 0.53, 0.76, and 0.82, respectively) and was lower for those with less than a high school education versus those who had completed college and for uninsured adults versus those with private insurance (adjusted prevalence ratios, 0.76 and 0.51, respectively).<\/p>\n “The findings highlight a major communication gap about CRC prevention in the clinical setting,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n